Introduction
There is evidence indicating that estrogens can induce the development and protection of nigrostriatal dopamine (DA) neurons in vivo (Kipp et al., 2006; Liu and Dluzen, 2007 ). Parkinson's disease (PD) is a neurodegenerative disorder characterized by a progressive and selective loss of midbrain DA neurons of the substantia nigra pars compacta. This decrease of DA neurons results in a dopamine depletion in the striatum, which impairs normal motor functions. Epidemiological studies show that PD is 1.5 to 2 times more common in men than in women (Baldereschi et al., 2000; Czlonkowska et al., 2006; Haaxma et al., 2007) ; recently, delayed onset and more benevolent progress have been reported for women when compared to men patients with PD, and these differences could be due to estrogens action (Haaxma et al., 2007) . Furthermore, in experimental animal models, numerous studies demonstrated that estrogens administration protects against neurotoxins such as 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (reviewed in Morissette et al., 2008) , methamphetamine (Dluzen and McDermott, 2002 ) and 6-hydroxy-DA (reviewed in Dluzen, 1997) that selectively destroy DA neurons of the substantia nigra. All these findings imply that estrogens play a protective role for DA neurons. In addition to this well-described action, in recent years a proliferative action of estradiol (E 2 ) has been reported for neural precursor cells (Brannvall et al., 2002; Martinez-Cerdeno et al., 2006; Wang et al., 2008) .
Embryonic stem cells (ESC) are pluripotent cell lines derived from the inner cell mass of pre-implantation embryos. Because of their ability to self-renew, proliferate undifferentiated in vitro, while maintaining the potential to differentiate into most cell types, ESC are useful to dissect critical steps of cell commitment. Furthermore, they also represent a potential source for cell replacement therapy (McKay, 2000) . In this context, it has been shown that midbrain DA neurons can be induced in vitro from mouse ESC with the 5-stage method and that these DA neurons have improved parkinsonism in rodents for over 32 weeks after grafting (Diaz et al., 2007; Kim et al., 2002; Rodriguez-Gomez et al., 2007) . We have previously reported the expression of sex steroid hormone receptors during this protocol. The last two phases of this procedure produce nestin-positive cells (stage 4, neural precursors) that respond to the application of Fibroblast growth factor Abbreviations: DA, dopamine; E 2 , estradiol; ER, estrogen receptor; ESC, embryonic stem cells; FGF, Fibroblast growth factor; GAPDH, Glyceraldehyde phosphate dehydrogenase; PD, Parkinson's disease; SHH, Sonic hedgehog; TH, tyrosine hydroxylase.
